Ayşen Çalıkuşu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ayşen Çalıkuşu has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Meltem Bahcelioglu
Department of Anatomy Faculty of Medicine, Neuroscience and Neurotechnology Center of Excellence (NÖROM), Neuropsychiatry Education, Research and Application Center Gazi University Ankara Türkiye
9 shared publications - Hale Gök Dağıdır
Department of Medical Biochemistry Faculty of Medicine, Neuroscience and Neurotechnology Center of Excellence Gazi University Ankara Türkiye
6 shared publications - Neslihan Bukan
Department of Medical Biochemistry Faculty of Medicine Gazi University Ankara Türkiye
6 shared publications - Ece Alim
Neuroscience and Neurotechnology Center of Excellence (NÖROM) Gazi University Ankara Türkiye
5 shared publications - Hayrunnisa Bolay
Neuroscience and Neurotechnology Center of Excellence (NÖROM), Gazi University, Ankara, Turkiye
5 shared publications - Kerem Atalar
Department of Anatomy Faculty of Medicine, Neuroscience and Neurotechnology Center of Excellence (NÖROM), Neuropsychiatry Education, Research and Application Center Gazi University Ankara Türkiye
5 shared publications
Latest Publications
- 31 August 2026
- Published by Deomed Publishing in Anatomy
- Vol. 20 (2) , 69-83
A morphometric and typological study of the clivus for guiding endoscopic skull base surgery
Objectives: Endoscopic transnasal transsphenoidal approaches to lesions involving the clivus carry several disadvantages for midline skull base lesions, including higher morbidity and a lesser extent of resection. This study aimed to investigate the anatomical detail of the clivus in order to identify failure criteria and improve success parameters. Methods: Clivus length, width, thickness and area, opisthion–dorsum sellae length, dorsum sellae–basion angle, and foramen magnum length and width were evaluated on 32 adult dry human skulls using ImageJ. The prevalence of clivus shape, border type and surface type was also determined. Results: Mean clivus length was 3.52±0.37 cm in females and 3.25±0.63 cm in males, and clivus width was 1.42±0.50 cm and 1.41±0.57 cm, respectively. Among clivus types, the long-straight type had the greatest length (4.16±0.25 cm) and the short-sloped type the shortest (2.98±0.36 cm). The most common clivus shape was the short-sloped type (56.25%), the most frequent border type was inward-curved (40.6%), and the most common surface type was concave (56.25%). An asymmetric shape was observed in 31.25% of specimens, an irregular surface in 25%, and asymmetric borders in 31.3%. Foramen magnum length was significantly greater in males (p<0.001). Conclusion: The long-straight clivus appears most suitable for transnasal/transclival access and tumour resection, whereas asymmetric types require careful preoperative evaluation. The symmetric border type showed a regular and balanced morphology, providing a consistent bony boundary that may aid intraoperative orientation.
- 31 August 2026
- Published by Deomed Publishing in Anatomy
- Vol. 20 (2) , 69-83
A morphometric and typological study of the clivus for guiding endoscopic skull base surgery
Objectives: Endoscopic transnasal transsphenoidal approaches to lesions involving the clivus carry several disadvantages for midline skull base lesions, including higher morbidity and a lesser extent of resection. This study aimed to investigate the anatomical detail of the clivus in order to identify failure criteria and improve success parameters. Methods: Clivus length, width, thickness and area, opisthion–dorsum sellae length, dorsum sellae–basion angle, and foramen magnum length and width were evaluated on 32 adult dry human skulls using ImageJ. The prevalence of clivus shape, border type and surface type was also determined. Results: Mean clivus length was 3.52±0.37 cm in females and 3.25±0.63 cm in males, and clivus width was 1.42±0.50 cm and 1.41±0.57 cm, respectively. Among clivus types, the long-straight type had the greatest length (4.16±0.25 cm) and the short-sloped type the shortest (2.98±0.36 cm). The most common clivus shape was the short-sloped type (56.25%), the most frequent border type was inward-curved (40.6%), and the most common surface type was concave (56.25%). An asymmetric shape was observed in 31.25% of specimens, an irregular surface in 25%, and asymmetric borders in 31.3%. Foramen magnum length was significantly greater in males (p<0.001). Conclusion: The long-straight clivus appears most suitable for transnasal/transclival access and tumour resection, whereas asymmetric types require careful preoperative evaluation. The symmetric border type showed a regular and balanced morphology, providing a consistent bony boundary that may aid intraoperative orientation.
- Open Access
- 8 June 2026
- Published by Wiley in Clinical and Translational Science
- Vol. 19 (6) , e70633
tVNS Mitigates Neuroinflammation and Nociception in a Rodent LPS Endotoxemia Model
The vagus nerve plays a modulatory role in the gut‐brain axis. Intestinal barrier dysfunction and lipopolysaccharide (LPS) leakage into the systemic circulation are associated with several conditions, such as irritable bowel syndrome (IBS) and migraine headache. This study investigates the impact of non‐invasive transauricular vagus nerve stimulation (tVNS) on the neuroinflammatory markers and pain behavior following an acute LPS challenge. Sprague–Dawley rats ( n = 28) were given LPS or vehicle and subjected to tVNS or sham intervention in an acute LPS animal model that mimics the systemic consequences of barrier dysfunction. Behaviors were evaluated at the baseline and 6 h later, complemented by testing the levels of serum and brain neuroinflammatory markers. Behavioral analyses revealed that LPS exposure reduced the time spent in the open arm, grooming duration, and periorbital mechanical pain thresholds, and increased freezing duration. The tVNS intervention reversed these behavioral changes induced by LPS. LPS administration triggered elevated serum levels of IL‐6, CGRP, haptoglobin, and VE‐cadherin. LPS also increased IL‐1β, PAR‐2, haptoglobin, CGRP, and HMGB1 levels in the brain tissue. The tVNS intervention reversed the effects observed in the brain, but it did not change the elevated levels of inflammatory molecules in the systemic circulation. tVNS has the potential to modulate neuroimmune interactions, with an early impact on the brain during LPS surge. tVNS may have potential therapeutic benefits in managing pain‐related disorders associated with LPS endotoxemia.
- 8 June 2026
- Published by Wiley in Clinical and Translational Science
- Vol. 19 (6) , e70633
Open AccesstVNS Mitigates Neuroinflammation and Nociception in a Rodent LPS Endotoxemia Model
The vagus nerve plays a modulatory role in the gut‐brain axis. Intestinal barrier dysfunction and lipopolysaccharide (LPS) leakage into the systemic circulation are associated with several conditions, such as irritable bowel syndrome (IBS) and migraine headache. This study investigates the impact of non‐invasive transauricular vagus nerve stimulation (tVNS) on the neuroinflammatory markers and pain behavior following an acute LPS challenge. Sprague–Dawley rats ( n = 28) were given LPS or vehicle and subjected to tVNS or sham intervention in an acute LPS animal model that mimics the systemic consequences of barrier dysfunction. Behaviors were evaluated at the baseline and 6 h later, complemented by testing the levels of serum and brain neuroinflammatory markers. Behavioral analyses revealed that LPS exposure reduced the time spent in the open arm, grooming duration, and periorbital mechanical pain thresholds, and increased freezing duration. The tVNS intervention reversed these behavioral changes induced by LPS. LPS administration triggered elevated serum levels of IL‐6, CGRP, haptoglobin, and VE‐cadherin. LPS also increased IL‐1β, PAR‐2, haptoglobin, CGRP, and HMGB1 levels in the brain tissue. The tVNS intervention reversed the effects observed in the brain, but it did not change the elevated levels of inflammatory molecules in the systemic circulation. tVNS has the potential to modulate neuroimmune interactions, with an early impact on the brain during LPS surge. tVNS may have potential therapeutic benefits in managing pain‐related disorders associated with LPS endotoxemia.
- 21 November 2025
- Published by Wiley in Developmental Neurobiology
- Vol. 86 (1) , e23019
Targeting Brain Plasticity: Vagal Nerve Stimulation as a Therapy for Autism‐Like Symptoms in a Valproic Acid Mouse Model
Autism spectrum disorder (ASD) is a multifactorial neurodevelopmental condition defined by social deficits, stereotypical or repetitive behaviors, and anxiety. This study evaluates the therapeutic potential of transauricular vagal nerve stimulation (tVNS) in a valproic acid (VPA)‐induced mouse model of ASD. The study comprised three groups: the control + sham (saline‐treated offsprings receiving sham stimulation), the autistic + sham (VPA‐treated offspring receiving sham stimulation), and the autistic + tVNS (VPA‐treated offsprings receiving tVNS). Male C57BL/6 mice exposed to VPA on embryonic day 12.5 were evaluated for behavioral and neurobiological alterations. tVNS was applied twice weekly for 3 weeks to investigate its effects on sociability, anxiety‐like behaviors, neurogenesis markers, and apoptosis pathways. Behavioral testing, including the three‐chamber test, mirrored chamber test, open field test, and elevated plus maze, revealed that tVNS significantly improved sociability and social preference indices, reduced social anxiety, and decreased general anxiety‐like behaviors in VPA‐induced mice. Histological and immunohistochemical analyses have shown a decrease in neuron density, brain‐derived neurotrophic factor (BDNF), and doublecortin (DCX) expression in the hippocampus, amygdala, and prefrontal cortex of VPA‐induced mice. Additionally, the increase in caspase‐3 immunoreactivity indicates increased apoptosis. tVNS treatment restored BDNF and DCX levels, promoting neurogenesis and synaptic plasticity while significantly reducing caspase‐3‐mediated apoptosis in affected brain regions. These findings suggest that tVNS may counteract the neural and behavioral deficits associated with ASD by modulating neurogenesis, neuronal plasticity, and apoptosis. The study highlights tVNS as a potential therapeutic intervention for ASD, emphasizing its role in targeting both behavioral alterations and underlying neurobiological mechanisms.
- 21 November 2025
- Published by Wiley in Developmental Neurobiology
- Vol. 86 (1) , e23019
Targeting Brain Plasticity: Vagal Nerve Stimulation as a Therapy for Autism‐Like Symptoms in a Valproic Acid Mouse Model
Autism spectrum disorder (ASD) is a multifactorial neurodevelopmental condition defined by social deficits, stereotypical or repetitive behaviors, and anxiety. This study evaluates the therapeutic potential of transauricular vagal nerve stimulation (tVNS) in a valproic acid (VPA)‐induced mouse model of ASD. The study comprised three groups: the control + sham (saline‐treated offsprings receiving sham stimulation), the autistic + sham (VPA‐treated offspring receiving sham stimulation), and the autistic + tVNS (VPA‐treated offsprings receiving tVNS). Male C57BL/6 mice exposed to VPA on embryonic day 12.5 were evaluated for behavioral and neurobiological alterations. tVNS was applied twice weekly for 3 weeks to investigate its effects on sociability, anxiety‐like behaviors, neurogenesis markers, and apoptosis pathways. Behavioral testing, including the three‐chamber test, mirrored chamber test, open field test, and elevated plus maze, revealed that tVNS significantly improved sociability and social preference indices, reduced social anxiety, and decreased general anxiety‐like behaviors in VPA‐induced mice. Histological and immunohistochemical analyses have shown a decrease in neuron density, brain‐derived neurotrophic factor (BDNF), and doublecortin (DCX) expression in the hippocampus, amygdala, and prefrontal cortex of VPA‐induced mice. Additionally, the increase in caspase‐3 immunoreactivity indicates increased apoptosis. tVNS treatment restored BDNF and DCX levels, promoting neurogenesis and synaptic plasticity while significantly reducing caspase‐3‐mediated apoptosis in affected brain regions. These findings suggest that tVNS may counteract the neural and behavioral deficits associated with ASD by modulating neurogenesis, neuronal plasticity, and apoptosis. The study highlights tVNS as a potential therapeutic intervention for ASD, emphasizing its role in targeting both behavioral alterations and underlying neurobiological mechanisms.
- Open Access
- 14 November 2025
- Published by MDPI AG in Antioxidants
- Vol. 14 (11) , 1360
CoQ10-Supported HIIT Modulates Skeletal Muscle and Hippocampal Biomarkers in Rats: A Randomized, Repeated-Measures, Post-Test Controlled Design
This study examined how coenzyme Q10-supported high-intensity interval training (HIIT) influences plasma lactate threshold, skeletal muscle oxidative capacity, circulating irisin and corticosterone, and hippocampal brain-derived neurotrophic factor (BDNF) and glial fibrillary acidic protein (GFAP) levels in rats. Forty-eight male Sprague Dawley rats (8 weeks old; 250.4 ± 11.2 g) were randomized into four groups: control (C), coenzyme Q10 (Supp), HIIT, and HIIT with coenzyme Q10 (HIITsupp). HIIT was performed five days per week on a treadmill following a four-stage familiarization. Coenzyme Q10 (5 mg/kg/day) was given by gavage 30 min before HIIT during weeks II–IV. Plasma lactate threshold, corticosterone, irisin, and citrate synthase (CS) activity were measured by ELISA, while hippocampal BDNF and GFAP were analyzed by both ELISA and immunohistochemistry. The HIITsupp group showed greater muscle mass, CS activity, plasma irisin, and hippocampal BDNF, along with lower GFAP and lactate threshold than the C, Supp, and HIIT groups. The Supp group had the lowest corticosterone, while the HIIT group maintained the highest lactate threshold before supplementation. Principal Component Analysis (PCA) indicated distinct clustering, with the C group closely associated with GFAP and corticosterone, whereas the HIITsupp group aligned with oxidative and neurotrophic markers. Coenzyme Q10-supported HIIT improved muscle oxidative capacity, lowered lactate, and modulated corticosterone, GFAP, and hippocampal BDNF, indicating integrated metabolic and neurobiological adaptations.
- 14 November 2025
- Published by MDPI AG in Antioxidants
- Vol. 14 (11) , 1360
Open AccessCoQ10-Supported HIIT Modulates Skeletal Muscle and Hippocampal Biomarkers in Rats: A Randomized, Repeated-Measures, Post-Test Controlled Design
This study examined how coenzyme Q10-supported high-intensity interval training (HIIT) influences plasma lactate threshold, skeletal muscle oxidative capacity, circulating irisin and corticosterone, and hippocampal brain-derived neurotrophic factor (BDNF) and glial fibrillary acidic protein (GFAP) levels in rats. Forty-eight male Sprague Dawley rats (8 weeks old; 250.4 ± 11.2 g) were randomized into four groups: control (C), coenzyme Q10 (Supp), HIIT, and HIIT with coenzyme Q10 (HIITsupp). HIIT was performed five days per week on a treadmill following a four-stage familiarization. Coenzyme Q10 (5 mg/kg/day) was given by gavage 30 min before HIIT during weeks II–IV. Plasma lactate threshold, corticosterone, irisin, and citrate synthase (CS) activity were measured by ELISA, while hippocampal BDNF and GFAP were analyzed by both ELISA and immunohistochemistry. The HIITsupp group showed greater muscle mass, CS activity, plasma irisin, and hippocampal BDNF, along with lower GFAP and lactate threshold than the C, Supp, and HIIT groups. The Supp group had the lowest corticosterone, while the HIIT group maintained the highest lactate threshold before supplementation. Principal Component Analysis (PCA) indicated distinct clustering, with the C group closely associated with GFAP and corticosterone, whereas the HIITsupp group aligned with oxidative and neurotrophic markers. Coenzyme Q10-supported HIIT improved muscle oxidative capacity, lowered lactate, and modulated corticosterone, GFAP, and hippocampal BDNF, indicating integrated metabolic and neurobiological adaptations.
- Open Access
- 17 October 2025
- Published by Springer Nature in The Journal of Headache and Pain
- Vol. 26 (1) , 1-15
Altered expressions of CGRP, SULT1A1, HMGB1, and HIF-1α in the trigeminal ganglion in medication overuse headache in female rats
Medication-overuse headache (MOH) is a female-predominant secondary headache generally associated with nonsteroidal anti-inflammatory drug overuse and chronification of migraine. MOH is associated with elevated serum levels of inflammatory and nociceptive molecules and intestinal leak in migraine patients. We aimed to characterize the changes in expression patterns of high mobility group box 1 (HMGB1) and hypoxia-inducible factor 1 alpha (HIF-1α) in the trigeminal ganglion cells, thereby offering new insights into the molecular mechanisms contributing to MOH. MOH was induced by oral piroxicam in female Sprague Dawley rats, and pain-related behaviors were assessed via periorbital mechanical withdrawal thresholds, head-face grooming, freezing, and head shaking during the metestrus and diestrus phases. The levels, and the cell type preference and nuclear or cytoplasmic localization for the expression of HMGB1, HIF-1α, calcitonin gene-related peptide (CGRP), and SULT1A1 in the trigeminal ganglia were examined using immunohistochemistry and Western blot analyses. Chronic piroxicam administration decreased periorbital withdrawal thresholds and increased nociceptive behaviors. CGRP-positive neuron number and CGRP levels are increased in the TG of the MOH group. HMGB1 immunoreactivity was observed in both neurons and satellite glial cells (SGCs), with enhanced cytoplasmic translocation and elevated total protein levels in the MOH group. HIF-1α was present in neurons and SGCs, with increased nuclear localization and expression in the MOH group. SULT1A1 was localized to the cytoplasm of trigeminal ganglion neurons, not detected in satellite glial cells, and was significantly downregulated in the MOH group. Our study showed for the first time that NSAID overuse headache is associated with a robust increase in CGRP, HMGB1, and HIF-1α and reduced SULT1A1 expression in the trigeminal ganglion. Increased nociceptive, inflammatory, and mitochondrial stress signaling in the trigeminal ganglion cells may drive sustained trigeminal nociceptive activity in MOH. Besides, reduced SULT1A1 expression in the trigeminal ganglion suggests reduced capacity of detoxification and catecholamine metabolism in MOH. The role of lipopolysaccharide leakage and systemic nociceptive drive on trigeminal neurons remains to be clarified.
- 17 October 2025
- Published by Springer Nature in The Journal of Headache and Pain
- Vol. 26 (1) , 1-15
Open AccessAltered expressions of CGRP, SULT1A1, HMGB1, and HIF-1α in the trigeminal ganglion in medication overuse headache in female rats
Medication-overuse headache (MOH) is a female-predominant secondary headache generally associated with nonsteroidal anti-inflammatory drug overuse and chronification of migraine. MOH is associated with elevated serum levels of inflammatory and nociceptive molecules and intestinal leak in migraine patients. We aimed to characterize the changes in expression patterns of high mobility group box 1 (HMGB1) and hypoxia-inducible factor 1 alpha (HIF-1α) in the trigeminal ganglion cells, thereby offering new insights into the molecular mechanisms contributing to MOH. MOH was induced by oral piroxicam in female Sprague Dawley rats, and pain-related behaviors were assessed via periorbital mechanical withdrawal thresholds, head-face grooming, freezing, and head shaking during the metestrus and diestrus phases. The levels, and the cell type preference and nuclear or cytoplasmic localization for the expression of HMGB1, HIF-1α, calcitonin gene-related peptide (CGRP), and SULT1A1 in the trigeminal ganglia were examined using immunohistochemistry and Western blot analyses. Chronic piroxicam administration decreased periorbital withdrawal thresholds and increased nociceptive behaviors. CGRP-positive neuron number and CGRP levels are increased in the TG of the MOH group. HMGB1 immunoreactivity was observed in both neurons and satellite glial cells (SGCs), with enhanced cytoplasmic translocation and elevated total protein levels in the MOH group. HIF-1α was present in neurons and SGCs, with increased nuclear localization and expression in the MOH group. SULT1A1 was localized to the cytoplasm of trigeminal ganglion neurons, not detected in satellite glial cells, and was significantly downregulated in the MOH group. Our study showed for the first time that NSAID overuse headache is associated with a robust increase in CGRP, HMGB1, and HIF-1α and reduced SULT1A1 expression in the trigeminal ganglion. Increased nociceptive, inflammatory, and mitochondrial stress signaling in the trigeminal ganglion cells may drive sustained trigeminal nociceptive activity in MOH. Besides, reduced SULT1A1 expression in the trigeminal ganglion suggests reduced capacity of detoxification and catecholamine metabolism in MOH. The role of lipopolysaccharide leakage and systemic nociceptive drive on trigeminal neurons remains to be clarified.
- Open Access
- 18 March 2025
- Published by Springer Nature in European Journal of Applied Physiology
- Vol. 125 (8) , 1-12
Evaluating the impact of coenzyme Q10 and high-intensity interval training on lactate threshold and Plasma blood gases in rats: a randomized controlled trial
Purpose: Coenzyme Q10 (Q10) is a mitochondrial coenzyme that facilitates ATP production via oxidative phosphorylation. This study hypothesized that Q10 enhances mitochondrial efficiency and lactate threshold, while high-intensity interval training (HIIT) promotes metabolic adaptations, improving glucose utilization and buffering capacity for faster recovery after high-intensity exercise. Methods: A randomized controlled trial was conducted using 24 male Sprague–Dawley rats (250.4 ± 6.1 g, 8 weeks old). The rats were allocated into four groups: control (C), coenzyme Q10 (CoQ10), HIIT, and HIIT + Q10. The Q10 administration involved a dosage of 10 mg/kg/day, given 30 min prior to the HIIT protocol. Lactate threshold, blood gas parameters, oximetry values, metabolite levels, and electrolyte status were analyzed utilizing the Radiometer 900 device. The blood samples were collected at the fifth and tenth minutes following the HIIT training trials. Results: The HIIT + Q10 group exhibited a significant reduction in lactate threshold (p < 0.01), maintaining values below average. Significant improvements in blood gas parameters, including pH, pO2, and pCO2, were observed in this group. Enhanced oxygen transport capacity was indicated by improved oximetry parameters (Hb, HCT, sO2) and reduced COHb levels. Additionally, positive changes in HCO3- and base values indicated reduced metabolic stress. Q10 supplementation also stabilized electrolytes, particularly K+ and Na+. Conclusion: The Q10 supplementation supported metabolic balance, improved oxygen transport, and stabilized acid–base levels during HIIT. It reduced lactate accumulation, enhanced glucose availability, and alleviated metabolic stress, thereby improving recovery efficiency and physiological adaptation.
- 18 March 2025
- Published by Springer Nature in European Journal of Applied Physiology
- Vol. 125 (8) , 1-12
Open AccessEvaluating the impact of coenzyme Q10 and high-intensity interval training on lactate threshold and Plasma blood gases in rats: a randomized controlled trial
Purpose: Coenzyme Q10 (Q10) is a mitochondrial coenzyme that facilitates ATP production via oxidative phosphorylation. This study hypothesized that Q10 enhances mitochondrial efficiency and lactate threshold, while high-intensity interval training (HIIT) promotes metabolic adaptations, improving glucose utilization and buffering capacity for faster recovery after high-intensity exercise. Methods: A randomized controlled trial was conducted using 24 male Sprague–Dawley rats (250.4 ± 6.1 g, 8 weeks old). The rats were allocated into four groups: control (C), coenzyme Q10 (CoQ10), HIIT, and HIIT + Q10. The Q10 administration involved a dosage of 10 mg/kg/day, given 30 min prior to the HIIT protocol. Lactate threshold, blood gas parameters, oximetry values, metabolite levels, and electrolyte status were analyzed utilizing the Radiometer 900 device. The blood samples were collected at the fifth and tenth minutes following the HIIT training trials. Results: The HIIT + Q10 group exhibited a significant reduction in lactate threshold (p < 0.01), maintaining values below average. Significant improvements in blood gas parameters, including pH, pO2, and pCO2, were observed in this group. Enhanced oxygen transport capacity was indicated by improved oximetry parameters (Hb, HCT, sO2) and reduced COHb levels. Additionally, positive changes in HCO3- and base values indicated reduced metabolic stress. Q10 supplementation also stabilized electrolytes, particularly K+ and Na+. Conclusion: The Q10 supplementation supported metabolic balance, improved oxygen transport, and stabilized acid–base levels during HIIT. It reduced lactate accumulation, enhanced glucose availability, and alleviated metabolic stress, thereby improving recovery efficiency and physiological adaptation.
- Open Access
- 14 October 2024
- Published by Wiley in FEBS Open Bio
- Vol. 15 (1) , 69-80
tVNS alters inflammatory response in adult VPA‐induced mouse model of autism: evidence for sexual dimorphism
Autism is a neurodevelopmental disorder with limited treatment alternatives and which incidence is increasing. Some research suggests that vagus nerve simulation might lead to the reduction of certain symptom. Therefore, we aimed to examine the effect of bilateral transcutaneous auricular vagus nerve stimulation (tVNS) on the inflammatory response in an adult valproic acid (VPA) induced mouse (C57BL6) model of autism for the first time. The autism model was induced by oral VPA administration (600 mg·kg−1) to C57BL/6 pregnant mice on E12.5 days. The study included three groups: the VPA Transcutaneous Auricular Stimulation Group (VPA + tVNS), the VPA Control Group (VPA + sham), and the Healthy Control Group (Control + sham). Each group included 16 mice (8 M/8 F). Our results show that serum IL‐1β and IL‐6 levels were significantly higher in male VPA‐exposed mice than controls. However, IL‐1β was significantly lower, and IL‐6, TNF‐ α, and IL‐22 were not different in female VPA‐exposed mice compared to the control group. Brain NLRP3 levels were significantly higher in both sexes in the VPA autism model (P < 0.05). tVNS application increased brain NLRP3 levels in both sexes and reduced serum IL‐1β levels in male mice. We conclude that cytokine dysregulation is associated with the VPA‐induced adult autism model, and the inflammatory response is more pronounced in male mice. tVNS application altered the inflammatory response and increased brain NLPR3 levels in both sexes. Further studies are needed to understand the beneficial or detrimental role of the inflammatory response in autism and its sexual dimorphism.
- 14 October 2024
- Published by Wiley in FEBS Open Bio
- Vol. 15 (1) , 69-80
Open AccesstVNS alters inflammatory response in adult VPA‐induced mouse model of autism: evidence for sexual dimorphism
Autism is a neurodevelopmental disorder with limited treatment alternatives and which incidence is increasing. Some research suggests that vagus nerve simulation might lead to the reduction of certain symptom. Therefore, we aimed to examine the effect of bilateral transcutaneous auricular vagus nerve stimulation (tVNS) on the inflammatory response in an adult valproic acid (VPA) induced mouse (C57BL6) model of autism for the first time. The autism model was induced by oral VPA administration (600 mg·kg−1) to C57BL/6 pregnant mice on E12.5 days. The study included three groups: the VPA Transcutaneous Auricular Stimulation Group (VPA + tVNS), the VPA Control Group (VPA + sham), and the Healthy Control Group (Control + sham). Each group included 16 mice (8 M/8 F). Our results show that serum IL‐1β and IL‐6 levels were significantly higher in male VPA‐exposed mice than controls. However, IL‐1β was significantly lower, and IL‐6, TNF‐ α, and IL‐22 were not different in female VPA‐exposed mice compared to the control group. Brain NLRP3 levels were significantly higher in both sexes in the VPA autism model (P < 0.05). tVNS application increased brain NLRP3 levels in both sexes and reduced serum IL‐1β levels in male mice. We conclude that cytokine dysregulation is associated with the VPA‐induced adult autism model, and the inflammatory response is more pronounced in male mice. tVNS application altered the inflammatory response and increased brain NLPR3 levels in both sexes. Further studies are needed to understand the beneficial or detrimental role of the inflammatory response in autism and its sexual dimorphism.
- 1 January 2024
- Published by Yuksek Ihtisas Universitesi Saglik Bilimleri Dergisi, Yuksek Ihtisas Universitesi in Yüksek İhtisas Üniversitesi Sağlık Bilimleri Dergisi
- p. 66-72
Brain-Gut Network in Inflammatory Bowel Diseases and the Role of Vagal Nerve in Neuroinflammation
In both normal and pathological situations, the brain and gut communicate. Intestinal inflammation is crucial in the progression of systemic inflammation and neuroinflammation. Inflammatory Bowel Diseases, neurodegeneration, and neuroinflammation all benefit from elucidating the molecular relationships between the gut and the brain. Crohn’s disease, ulcerative colitis, and indeterminate colitis are chronic disorders characterized by recurring episodes of gastrointestinal inflammation. Inflammatory bowel disease has evolved into a global disease in the 21st century, affecting around 6.8 million individuals and increasing in prevalence. According to growing evidence using clinical, epidemiological, and experimental data, Inflammatory Bowel Disease predisposes people to central nervous system disorders. The goal of this review is to address current knowledge in inflammatory bowel disorders, to analyze the interconnections between Inflammatory Bowel Diseases and neurodegenerative and neuroinflammatory diseases all along the gut-brain axis, and to emphasize the role of neuroinflammation in Inflammatory Bowel Diseases. Finally, we address vagal nerve stimulation as a potential treatment because it is a critical component of brain-gut interactions and exerts a dual antiinflammatory role via its afferent and efferent fibers. Keywords: Inflammatory bowel diseases, brain-gut axis, microbiota, neuroinflammation, neurodegeneration, vagal nerve stimulation
- 1 January 2024
- Published by Yuksek Ihtisas Universitesi Saglik Bilimleri Dergisi, Yuksek Ihtisas Universitesi in Yüksek İhtisas Üniversitesi Sağlık Bilimleri Dergisi
- p. 66-72
Brain-Gut Network in Inflammatory Bowel Diseases and the Role of Vagal Nerve in Neuroinflammation
In both normal and pathological situations, the brain and gut communicate. Intestinal inflammation is crucial in the progression of systemic inflammation and neuroinflammation. Inflammatory Bowel Diseases, neurodegeneration, and neuroinflammation all benefit from elucidating the molecular relationships between the gut and the brain. Crohn’s disease, ulcerative colitis, and indeterminate colitis are chronic disorders characterized by recurring episodes of gastrointestinal inflammation. Inflammatory bowel disease has evolved into a global disease in the 21st century, affecting around 6.8 million individuals and increasing in prevalence. According to growing evidence using clinical, epidemiological, and experimental data, Inflammatory Bowel Disease predisposes people to central nervous system disorders. The goal of this review is to address current knowledge in inflammatory bowel disorders, to analyze the interconnections between Inflammatory Bowel Diseases and neurodegenerative and neuroinflammatory diseases all along the gut-brain axis, and to emphasize the role of neuroinflammation in Inflammatory Bowel Diseases. Finally, we address vagal nerve stimulation as a potential treatment because it is a critical component of brain-gut interactions and exerts a dual antiinflammatory role via its afferent and efferent fibers. Keywords: Inflammatory bowel diseases, brain-gut axis, microbiota, neuroinflammation, neurodegeneration, vagal nerve stimulation
- Open Access
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S570
TRANSAURICULAR VAGAL NERVE STIMULATION EFFECTS ON PRO- AND ANTI-INFLAMMATORY CYTOKINES IN AN EXPERIMENTAL MODEL OF AUTISTIC MICE
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S570
Open AccessTRANSAURICULAR VAGAL NERVE STIMULATION EFFECTS ON PRO- AND ANTI-INFLAMMATORY CYTOKINES IN AN EXPERIMENTAL MODEL OF AUTISTIC MICE
- Open Access
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S75
BILATERAL TRANSAURICULAR VAGAL NERVE STIMULATION MODIFIES SOCIAL ADAPTION, ANXIETY, AND NEURODEVELOPMENTAL BIOMARKERS IN AN AUTISM MODEL: SEX MATTERS
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S75
Open AccessBILATERAL TRANSAURICULAR VAGAL NERVE STIMULATION MODIFIES SOCIAL ADAPTION, ANXIETY, AND NEURODEVELOPMENTAL BIOMARKERS IN AN AUTISM MODEL: SEX MATTERS